One in the eye for Illumina as Roche buys prenatal test maker
This article was originally published in Clinica
Executive Summary
Roche has acquired Ariosa Diagnostics, a privately-held US developer of blood tests used to detect Down syndrome and genetic abnormalities in the foetus.